Breaks Categories: Stock Spotlights

MondayNov 05, 2018 12:13 pm

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Driving Opportunities for Growth through Acquisitions

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) recently acquired HemPoland, increasing its opportunities for growth in the European market as part of the company’s international strategy. An article discussing the acquisition reads, “According to The Green Organic Dutchman CEO Brian Athaide, the transaction is a key milestone in the company’s long-term acquisition strategy. It delivers immediate revenue to shareholders while opening up a new vertical for the company. It also provides evidence of the company’s growth toward its goal of having operations in 12 countries on three continents by the end of…

Continue Reading

MondayOct 29, 2018 1:24 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Holds Robust IP Portfolio Protecting DehydraTECH Technology

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) drug delivery platform DehydraTECH employs its patented technology to improve bio-absorption and bioavailability of active ingredients while covering unpleasant tastes. A recent article discussing the company’s technology reads, “Lexaria’s disruptive DehydraTECH drug delivery platform is protected by a robust suite of patents granted or pending worldwide. It has been proven effective in multiple international studies in greatly assisting rapidity and quantity of absorption of a range of lipophilic (i.e., fat-soluble), bioactive molecules – such as those contained in cannabinoids (CBD), nicotine, non-steroidal anti-inflammatory drugs (NSAIDs) and other molecules. DehydraTECH offers a healthier, oral ingestion…

Continue Reading

MondayOct 22, 2018 10:57 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Has Filed New Patent Application in Strategic Effort to Build Global Portfolio

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), in a strategic effort to build its global intellectual property (IP) portfolio, has filed a new patent application for its proprietary absorption technology platform. An article discussing this reads, “It has filed a provisional application in a tenth patent family relating to the applicability of DehydraTECH’s imparting benefits to tobacco leaves to deliver compounds that may or may not include nicotine. That patent family is ‘Lipophilic Active Agent Infused Tobacco Leaves and/or Tobacco Materials and Methods of Use Thereof.’” To view the full article, visit http://cnw.fm/m6b2B About Lexaria Bioscience Corp. Lexaria Bioscience Corp. licenses…

Continue Reading

FridayOct 19, 2018 10:46 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Focused on Innovative Nicotine Delivery to Provide Healthier Alternatives to Lighting Up

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is on a quest in the development of healthier nicotine ingestion methods to provide consumers alternatives to lighting up. A recent article discussing the company’s novel drug delivery platform reads, “In a press release from August 2018, Lexaria announced a second-generation study in 40 rats. The study resulted in Lexaria’s formulation being four-times faster at reaching its peak level in brain tissue than the non-enhanced control formulation. In a press release  (http://cnw.fm/4SuIM), Chris Bunka, chief executive officer of Lexaria, stated, ‘DehydraTECH delivery technology continues to demonstrate its superior effectiveness in delivering nicotine without the…

Continue Reading

FridayOct 12, 2018 10:56 am

CannabisNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Seizing Opportunity as Public Opinion of CBD Improves

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is a hemp-cultivated cannabinoid innovator poised to seize its opportunity to profit as the public becomes more accepting and understanding of the potential health benefits of cannabis. A recent article discussing the company reads: “While the idea of drinkable cannabis was once considered unthinkable among marijuana’s recreational smokers, recent studies have shown that beer consumption has decreased significantly in the United States where cannabis has been legalized  (http://cnw.fm/2gmHG), prompting industry efforts to combine the two products and retain the consumer base, or even increase it. … Cannabis’ reputation has transformed from that of…

Continue Reading

TuesdayOct 09, 2018 3:05 pm

CannabisNewsBreaks – BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) Technology Enables Consumers to Ensure Purchase of Safe, Quality-tested Products

BLOCKStrain Technology (TSX.V: DNAX) (OTC: BKKSF) is investing in technological means to offer the transparency desired by businesses and consumers within the cannabis pipeline amid recent lab testing concerns. Using its easily integrated BLOCKStrain platform, consumers are able to distinguish between high- and low-quality products. A recent article discussing the company reads: “BLOCKStrain’s proprietary technology will serve clients at both ends of the production pipeline and those in between. Growers want to know that their product is making it to market in good condition. Consumers want to know that the product they buy was manufactured by a company invested in…

Continue Reading

MondayOct 08, 2018 1:51 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Strengthens IP Portfolio

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is building its strategic intellectual property (“IP”) portfolio with two recent Notices of Allowance from the U.S. Patent and Trademark Office (“USPTO”) as well as the addition of three new patents in Australia. The company anticipates receiving additional patents in the U.S. by the end of the year. An article discussing Lexaria reads, “If all are issued, LXRP will then hold 12 issued patents within its first patent family, “Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof.” It would strengthen LXRP’s IP claims in both countries. All new…

Continue Reading

FridayOct 05, 2018 1:38 pm

CannabisNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Quickly Progresses Into a Global Strategic Growth Platform

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF), a unique investment and operating platform, has quickly advanced from its roots and recently began trading on the TSX Venture Exchange. The company was originally founded to diversify Canopy Growth Corp.’s (TSX: WEED) (NYSE: CGC) cannabis supply streams. A recent article discussing the company reads: “The Company is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. The Company works collaboratively with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. The Company has developed an investment ecosystem of complementary cannabis operating companies that…

Continue Reading

FridayOct 05, 2018 11:01 am

CannabisNewsBreaks – Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Raising Funds through Sale of Units

Sunniva (CSE: SNN) (OTCQX: SNNVF) recently revealed its intention to raise C$20 million through the sale of units of the company to a syndicate of underwriters, detailed in a company press release (http://cnw.fm/ZMw2T). The terms of the sale are an amendment of a previously announced agreement to sell 1.9 million units. An article discussing the company’s plan reads, “Sunniva announced that the syndicate will purchase 3.8 million units priced at C$5.27 per unit, an amendment of the previously publicized agreement which said that the syndicate was to buy 1.9 million units. Subject to the approval of the Canadian Securities Exchange,…

Continue Reading

WednesdayOct 03, 2018 3:23 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Extends List of Applicable Uses for Innovative Drug Delivery Platform

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) continues to leverage its drug delivery platform technology in exciting new markets. An article discussing the company reads, “It has patents granted in the U.S. and Australia for applications of its DehydraTECH™ technology. Moreover, the company has many patents pending in over 40 nations. Lexaria Bioscience’s business strategy involves expanding the applicability of its technology within and beyond the cannabinoid sector. Recently upgraded to the OTC Markets’ OTCQX Best Market, Lexaria Bioscience is based in Kelowna, British Columbia. … The DehydraTECH™ drug delivery platform promotes healthier ingestion methods. It considerably improves the body’s ability…

Continue Reading